Holen Sie sich die Stockscreener-App
4.095
0.88%
-0.035
Schlusskurs vom Vortag:
$4.13
Offen:
$4.11
24-Stunden-Volumen:
668.93K
Relative Volume:
0.15
Marktkapitalisierung:
$499.77M
Einnahmen:
$44.55M
Nettoeinkommen (Verlust:
$-83.78M
KGV:
-5.2676
EPS:
-0.7774
Netto-Cashflow:
$-52.99M
1W Leistung:
+1.33%
1M Leistung:
-3.00%
6M Leistung:
-31.43%
1J Leistung:
+51.06%
1-Tages-Spanne:
$4.09
$4.16
1-Wochen-Bereich:
$4.04
$4.24
52-Wochen-Spanne:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Firmenname
Aquestive Therapeutics Inc
Sektor
Telefon
908-941-1900
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.095 | 504.05M | 44.55M | -83.78M | -52.99M | -0.7774 |
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.25 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.935 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.68 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
555.89 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-28 | Eingeleitet | Raymond James | Outperform |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-04-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-01-03 | Eingeleitet | Lake Street | Buy |
| 2018-08-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-08-20 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - globenewswire.com
AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-04-05 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Aquestive Therapeutics, Inc. to Contact the Firm Today! | NDAQ:AQST | Press Release - Stockhouse
Published on: 2026-04-05 15:45:00 - baoquankhu1.vn
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Aquestive Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
AQST SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - prnewswire.com
Lake Street adjusts Aquestive Therapeutics, Inc. (AQST) valuation model on expected approval delay - MSN
Bernstein Liebhard LLP Reminds Aquestive Shareholders of Lawsuit - National Today
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - bdtonline.com
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) ... - bdtonline.com
AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - prnewswire.com
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Aquestive Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
AQST Stock Price, Quote & Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
Aquestive Therapeutics, Inc. (AQST) stock price, news, quote and history - Yahoo Finance UK
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill
AQST Stockholders Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive - GlobeNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky - prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST - ChartMill
User - The Chronicle-Journal
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline - tipranks.com
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Insmed (INSM) - The Globe and Mail
AQST Stockholders Have Rights – If You Lost Money Investing - globenewswire.com
AQST Shareholders Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST) - TMX Newsfile
Analysts Are Bullish on These Healthcare Stocks: Alumis Inc. (ALMS), Aquestive Therapeutics (AQST) - The Globe and Mail
AQST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aquestive Therapeutics, Inc. Securities Lawsuit — The Gross Law Firm - Morningstar
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - globenewswire.com
Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3 - Insider Monkey
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutic - The National Law Review
AQST PE Ratio & Valuation, Is AQST Overvalued - Intellectia AI
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
AQST Investor Alert: Aquestive Therapeutics Faces Securities Fraud Lawsuit - National Today
Bragar Eagel & Squire Urges Aquestive Investors to Contact Firm Before Deadline - National Today
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Significant ... - bdtonline.com
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before Upcoming Lead Plaintiff Deadline - The Norfolk Daily News
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - globenewswire.com
Aquestive Therapeutics Completes FDA Type A Meeting for Anaphylm, Plans NDA Resubmission in Q3 2026 - Minichart
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting - TipRanks
Aquestive Therapeutics | 8-K: Current report - Moomoo
Aquestive Therapeutics Receives FDA's Preliminary Comments on Anaphylm Study Designs - marketscreener.com
Aquestive reaffirms Q3 2026 NDA resubmission for Anaphylm By Investing.com - Investing.com Canada
Aquestive completes Type A FDA meeting, reaffirms Q3 2026 Anaphylm NDA resubmission - TradingView
FDA Type A meeting guides Aquestive (NASDAQ: AQST) Anaphylm NDA path - Stock Titan
Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film - Yahoo Finance
AQST Stock Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
ROSEN Law Firm Urges Aquestive Therapeutics Investors to Seek Legal Counsel - National Today
ROSEN, THE FIRST FILING FIRM, Encourages Franklin BSP Realty Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FBRT - GlobeNewswire Inc.
Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aquestive Therapeutics Inc-Aktie (AQST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Barber Daniel | President and CEO |
Mar 10 '26 |
Sale |
4.17 |
180,677 |
753,965 |
1,004,753 |
| BRAENDER LORI J | Chief Legal Officer |
Mar 10 '26 |
Sale |
4.17 |
40,102 |
167,346 |
442,879 |
| Cioffi Melina | SVP, Regulatory Affairs |
Mar 10 '26 |
Sale |
4.17 |
25,311 |
105,623 |
274,867 |
| TOTH A ERNEST JR | Chief Financial Officer |
Mar 10 '26 |
Sale |
4.17 |
58,254 |
243,094 |
376,112 |
| Korczynski Sherry | Chief Commercial Officer |
Mar 10 '26 |
Sale |
4.17 |
15,741 |
65,687 |
241,117 |
| Jung Cassie | Chief Operating Officer |
Mar 10 '26 |
Sale |
4.17 |
45,791 |
191,086 |
274,980 |
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):